Abstract.
Objective: To identify the site(s) in tumor necrosis factor (TNFα), interleukin-6 (IL-6), and macrophage inflammatory protein-1α (MIP-1α) biosynthesis that is blocked by SB202190, a selective inhibitor of p38-mitogen activated protein kinase (p38). ¶Materials: Human blood monocytes isolated by centrifugal elutriation. ¶Methods: Monocytes were stimulated with lipopolysaccharide in the presence of 0, 0.3, 1 and 3 μM SB202190. Induced TNFα, IL-6, and MIP-1α protein and mRNA were measured by ELISA and quantitative RT-PCR, respectively. The half-lives of cytokine mRNA levels were determined following treatment of cells with actinomycin D or SB202190. ¶Results: SB202190 suppressed >60% of lipopolysaccharide-induced TNFα, IL-6, and MIP-1α protein and mRNA expression. Suppressed mRNA levels could be attributed to a >2 to 7-fold reduction in cytokine mRNA half-lives. In contrast, SB202190 did not destabilize mRNAs encoding interferon-induced gene 15 protein and glyceraldehyde-3-phosphate dehydrogenase. ¶Conclusions: Specific mRNA destabilization represents an important and novel site of action for the cytokine suppressive effects of p38 inhibitors.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received 13 May 1999; returned for revision 14 June 1999; accepted by G. Letts 21 July 1999
Rights and permissions
About this article
Cite this article
Wang, SW., Pawlowski, J., Wathen, S. et al. Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflamm. res. 48, 533–538 (1999). https://doi.org/10.1007/s000110050499
Issue Date:
DOI: https://doi.org/10.1007/s000110050499